193 related articles for article (PubMed ID: 8095411)
21. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
[TBL] [Abstract][Full Text] [Related]
23. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
[TBL] [Abstract][Full Text] [Related]
24. Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.
Robertson KW; Reeves JR; Smith G; Keith WN; Ozanne BW; Cooke TG; Stanton PD
Cancer Res; 1996 Aug; 56(16):3823-30. PubMed ID: 8706030
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
26. Role of HER2 gene overexpression in breast carcinoma.
Ménard S; Tagliabue E; Campiglio M; Pupa SM
J Cell Physiol; 2000 Feb; 182(2):150-62. PubMed ID: 10623878
[TBL] [Abstract][Full Text] [Related]
27. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization.
Ishikawa T; Kobayashi M; Mai M; Suzuki T; Ooi A
Am J Pathol; 1997 Sep; 151(3):761-8. PubMed ID: 9284825
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of erbB-2 gene amplification in bladder cancer.
Sauter G; Moch H; Moore D; Carroll P; Kerschmann R; Chew K; Mihatsch MJ; Gudat F; Waldman F
Cancer Res; 1993 May; 53(10 Suppl):2199-203. PubMed ID: 8097962
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical assay (IHC) to study C-erbB-2 status of breast cancer using monoclonal antibody CIBCgp185.
Meenakshi A; Kumar RS; Ganesh V; Sivakumar N
Hum Antibodies; 2003; 12(4):123-7. PubMed ID: 15156100
[TBL] [Abstract][Full Text] [Related]
31. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
[TBL] [Abstract][Full Text] [Related]
32. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
33. Amplification of oncogenes and disease prognosis.
Jandrig B
Arch Geschwulstforsch; 1990; 60(2):141-8. PubMed ID: 2187430
[TBL] [Abstract][Full Text] [Related]
34. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
[TBL] [Abstract][Full Text] [Related]
35. c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.
Falck VG; Gullick WJ
J Pathol; 1989 Oct; 159(2):107-11. PubMed ID: 2572685
[TBL] [Abstract][Full Text] [Related]
36. The role of the HER-2/neu oncogene in gynecologic cancers.
Cirisano FD; Karlan BY
J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
[TBL] [Abstract][Full Text] [Related]
37. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
38. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
39. Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification.
Kasprzyk PG; Sullivan TL; Hunt JD; Gubish CT; Scoppa CA; Oelkuct M; Bird R; Fischer PH; Siegfried JM; King CR
Clin Cancer Res; 1996 Jan; 2(1):75-80. PubMed ID: 9816093
[TBL] [Abstract][Full Text] [Related]
40. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
